K-Ras G12C-IN-1

CAS No. 1629265-17-3

K-Ras G12C-IN-1( —— )

Catalog No. M12441 CAS No. 1629265-17-3

A novel and irreversible inhibitor of mutant K-ras G12C.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 314 Get Quote
50MG 1791 Get Quote
100MG 3222 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    K-Ras G12C-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel and irreversible inhibitor of mutant K-ras G12C.
  • Description
    A novel and irreversible inhibitor of mutant K-ras G12C.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    Ras
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1629265-17-3
  • Formula Weight
    448.3423
  • Molecular Formula
    C22H23Cl2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 40 mg/mL
  • SMILES
    COC1=C(C=C(C(=C1)Cl)C2=CC=CC=C2Cl)NCC(=O)N3CCN(CC3)C(=O)C=C
  • Chemical Name
    2-Propen-1-one, 1-[4-[2-[(2',6-dichloro-4-methoxy[1,1'-biphenyl]-3-yl)amino]acetyl]-1-piperazinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. From PCT Int. Appl. (2014), WO 2014152588 A1 20140925.
molnova catalog
related products
  • 6H05

    6H05 is a selective and allosteric oncogenic mutant K-Ras(G12C) inhibitor.

  • Oncrasin 1

    Oncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.

  • SAH-SOS1A

    KRas/son of sevenless 1 (SOS1) interaction inhibitor. Binds within nucleotide binding pocket of KRas (Kd values are 106 - 176 nM for wild type KRas and various KRas mutants). Inhibits nucleotide binding to KRas in a concentration dependent manner. Displays cytotoxicity in KRas-driven cancer cell lines and inhibits downstream ERK-MAPK signaling. Cell permeable.